期刊
MOLECULAR AND CELLULAR BIOLOGY
卷 30, 期 7, 页码 1746-1756出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.00996-09
关键词
-
资金
- Heart and Stroke Foundation of Ontario [NA 6656]
- CIHR [MOP-82756, MOP-89919]
- NIH-Fogarty [R21 TW007800-02]
- PRONEX-FAPEMIG
- CNPq
- FAPEMIG
- Instituto do Milenio Toxins/MCT
- Department of Foreign Affairs and International Trade (Canada)
- Heart and Stroke Foundation of Canada
Overwhelming evidence supports the importance of the sympathetic nervous system in heart failure. In contrast, much less is known about the role of failing cholinergic neurotransmission in cardiac disease. By using a unique genetically modified mouse line with reduced expression of the vesicular acetylcholine transporter (VAChT) and consequently decreased release of acetylcholine, we investigated the consequences of altered cholinergic tone for cardiac function. M-mode echocardiography, hemodynamic experiments, analysis of isolated perfused hearts, and measurements of cardiomyocyte contraction indicated that VAChT mutant mice have decreased left ventricle function associated with altered calcium handling. Gene expression was analyzed by quantitative reverse transcriptase PCR and Western blotting, and the results indicated that VAChT mutant mice have profound cardiac remodeling and reactivation of the fetal gene program. This phenotype was attributable to reduced cholinergic tone, since administration of the cholinesterase inhibitor pyridostigmine for 2 weeks reversed the cardiac phenotype in mutant mice. Our findings provide direct evidence that decreased cholinergic neurotransmission and underlying autonomic imbalance cause plastic alterations that contribute to heart dysfunction.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据